P Kaleebu
Overview
Explore the profile of P Kaleebu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
733
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zacharopoulou P, Marchi E, Ogbe A, Robinson N, Brown H, Jones M, et al.
Sci Rep
. 2022 Jan;
12(1):462.
PMID: 35013427
Although certain individuals with HIV infection can stop antiretroviral therapy (ART) without viral load rebound, the mechanisms under-pinning 'post-treatment control' remain unclear. Using RNA-Seq we explored CD4 T cell gene...
2.
Massah G, Zhang W, Birungi J, Nanfuka M, Zhu J, Okoboi S, et al.
HIV Med
. 2021 Mar;
22(6):512-518.
PMID: 33730434
Objectives: We conducted an analysis to determine if differences in health-seeking behaviour can explain gender disparities in mortality among long-term survivors receiving antiretroviral therapy (ART) in rural Uganda. Methods: From...
3.
Nash S, Dietrich J, Ssemata A, Herrera C, OHagan K, Else L, et al.
Trials
. 2020 Oct;
21(1):900.
PMID: 33121503
Background: HIV remains a major public health issue, especially in Eastern and Southern Africa. Pre-exposure prophylaxis is highly effective when adhered to, but its effectiveness is limited by cost, user...
4.
Birungi J, Cui Z, Okoboi S, Kapaata A, Munderi P, Mukajjanga C, et al.
HIV Med
. 2019 Aug;
21(1):21-29.
PMID: 31432614
Objectives: The current World Health Organization and Uganda Ministry of Health HIV treatment guidelines recommend that asymptomatic patients who have a viral load (VL) ≥ 1000 HIV-1 RNA copies/mL should...
5.
Fily F, Ayikobua E, Ssemwanga D, Nicholas S, Kaleebu P, Delaugerre C, et al.
Trop Med Int Health
. 2018 Jul;
23(10):1075-1083.
PMID: 30058269
Objectives: The number of patients on second-line antiretroviral therapy is growing, but data on HIV drug resistance patterns at failure in resource-constrained settings are scarce. We aimed to describe drug...
6.
Barr A, Young E, Smeeth L, Newton R, Seeley J, Ripullone K, et al.
Glob Health Epidemiol Genom
. 2018 Jun;
1:e19.
PMID: 29868211
With the changing distribution of infectious diseases, and an increase in the burden of non-communicable diseases, low- and middle-income countries, including those in Africa, will need to expand their health...
7.
Ekoru K, Young E, Adebamowo C, Balde N, Hennig B, Kaleebu P, et al.
Glob Health Epidemiol Genom
. 2017 Dec;
1:e5.
PMID: 29276615
The burden and aetiology of type 2 diabetes (T2D) and its microvascular complications may be influenced by varying behavioural and lifestyle environments as well as by genetic susceptibility. These aspects...
8.
Ekoru K, Murphy G, Young E, Delisle H, Jerome C, Assah F, et al.
Int J Obes (Lond)
. 2017 Nov;
PMID: 29087388
Background: Waist circumference (WC) thresholds derived from western populations continue to be used in sub-Saharan Africa (SSA) despite increasing evidence of ethnic variation in the association between adiposity and cardiometabolic...
9.
Hassan A, Hare J, Kamini G, Yindom L, Kamali A, Karita E, et al.
Virus Evol
. 2017 Aug;
3(Suppl 1).
PMID: 28845248
No abstract available.
10.
Kamali A, Nsubuga R, Ruzagira E, Bahemuka U, Asiki G, Price M, et al.
Sex Transm Infect
. 2016 Mar;
92(6):447-54.
PMID: 26933046
Objectives: To describe HIV heterogeneity in rural Uganda using incidence data collected between January 2012 and December 2014 among fishing cohort (FC) and in an adjacent rural general population cohort...